VanA-mediated high level glycopeptide resistance in MRSA. (Q44298346)

1 December 2017

VanA-mediated high level glycopeptide resistance in MRSA. (English)

1 reference

1 December 2017

Bruno González-Zorn

1

1 reference

PubMed ID

12560187

1 December 2017

Patrice Courvalin

series ordinal

2

1 reference

1 December 2017

1 February 2003

1 reference

Lancet Infectious Diseases

1 December 2017

1 reference

1 December 2017

3

1 reference

1 December 2017

67-68

1 reference

1 December 2017

2

1 reference

Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900510-3

7 January 2021

Glycopeptide resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900510-3

7 January 2021

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900510-3

7 January 2021

Glycopeptide-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900510-3

7 January 2021

Vancomycin resistance in staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900510-3

7 January 2021

Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900510-3

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900510-3

7 January 2021

10.1016/S1473-3099(03)00510-3

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12560187